Erdafitinib in patients with advanced solid tumours with FGFR alterations (RAGNAR): an international, single-arm, phase 2 study.

The Lancet. Oncology(2023)

引用 10|浏览40
暂无评分
摘要
Janssen Research & Development.
更多
查看译文
关键词
fgfr alterations,advanced solid tumours,single-arm
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要